Penserra Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-17,908
| Closed | -$330K | – | 1454 |
|
|
2021
Q4 | $330K | Buy |
17,908
+3,412
| +24% | +$62.9K | 0.01% | 578 |
|
|
2021
Q3 | $443K | Buy |
14,496
+2,331
| +19% | +$71.2K | 0.01% | 528 |
|
|
2021
Q2 | $667K | Buy |
12,165
+8,165
| +204% | +$448K | 0.01% | 447 |
|
|
2021
Q1 | $236K | Buy |
4,000
+520
| +15% | +$30.7K | ﹤0.01% | 554 |
|
|
2020
Q4 | $130K | Buy |
3,480
+326
| +10% | +$12.2K | ﹤0.01% | 583 |
|
|
2020
Q3 | $170K | Sell |
3,154
-779
| -20% | -$42K | 0.01% | 454 |
|
|
2020
Q2 | $989K | Sell |
3,933
-1,018
| -21% | -$256K | 0.05% | 275 |
|
|
2020
Q1 | $978K | Buy |
+4,951
| New | +$978K | 0.07% | 267 |
|